CHEST-CA: Study of Chest Pain and Hidden Cardiac Amyloidosis
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Screening thourgh examinations including bonescintigraphy.
- Who it may be relevant to
- Registry conditions: Cardiac Amyloidosis, Chest Pain. Basic parameters: from 65 years · Male.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Denmark
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The objective of this observational, prospective study is to determine the prevalence of Cardiac Amyloidosis (CA) in males over the age of 65 who experience chest pain but show no signs of coronary artery disease (CAD). Prior to inclusion, all patients will have undergone a CT coronary angiogram or an Rb-PET scan to rule out the possibility of CAD. Participants will be subject to several examinations, including blood tests, urine samples, ECG, echocardiography, and bone scintigraphy. An endomyocardial biopsy may be conducted if necessary.
Interventions
- Other Screening thourgh examinations including bonescintigraphy
Clinical examination, blood samples, echo, bone scintigraphy
Primary outcome measures
- Prevalence of ATTR-CA in patients experiencing chest pain [Time frame: Up to 4 weeks]
Eligibility criteria
Inclusion criteria
No signs of CAD through Rb-PET and/or CT coronary arteriogram
Exclusion criteria
Previous history of amyloidosis
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Screening
Study locations
Denmark · 1 center
- Rigshospitalet — Copenhagen
Identifiers
NCT: NCT07435168 · H-24002324